VIZGEN INC

VIZGEN INC specializes in the design, manufacturing, and support of advanced spatial transcriptomics instrumentation and associated consumables for high-resolution molecular analysis in biological research. Their core capabilities center on the development of the MERSCOPE platform—a precision instrument enabling multiplexed, single-cell gene expression mapping with spatial context—alongside compatible FFPE sample preparation kits, slide containers, and custom gene panels. The company provides end-to-end technical support, including repair and maintenance of complex electronic and precision equipment, ensuring operational continuity in sensitive laboratory environments. Their technical expertise spans microfluidics, optical imaging systems, bioinformatics integration, and molecular assay development, with a distinct focus on translating cutting-edge genomics research into robust, deployable laboratory tools. VIZGEN INC maintains a consistent and deep relationship with the Department of Health and Human Services, delivering mission-critical instruments and services that support biomedical research initiatives across HHS components such as NCATS and other research arms. Their work for HHS includes pilot studies, proof-of-principle validations, and sustained instrument support, indicating a trusted partnership in advancing translational science and precision medicine. The contractor’s primary industry focus is analytical laboratory instrument manufacturing, specifically in the niche of spatial genomics platforms. This positions them at the intersection of life sciences instrumentation and molecular biology, serving government-funded research institutions focused on cancer, neuroscience, and immunology. Their market differentiation lies in enabling high-plex, spatially resolved transcriptomics in formalin-fixed tissues—a capability critical for clinical and preclinical research. VIZGEN INC is a small business entity headquartered in Cambridge, Massachusetts, with no government certifications on record. Their geographic and operational footprint is centered in the Boston biotech corridor, aligning them with leading academic and federal research ecosystems. They operate as a specialized technology provider serving the federal life sciences market with proprietary instrumentation and service solutions.